Metaxalone
CAS 1665-48-1 22 FDA-DMF suppliersSmall Molecule
Overview
Metaxalone is a muscle relaxant prescribed to relieve discomfort associated with acute skeletal muscle conditions. It is typically used as an adjunct to rest, physical therapy, and other measures to relieve discomfort.
API suppliers (22)
Suppliers of Metaxalone backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.
- ANGELINI ACRAF SPA1 active DMF
- RISING PHARMA HOLDINGS INCUnited States1 active DMF
- RISING PHARMA HOLDINGS INCUnited States1 active DMF
- ANGELINI ACRAF SPA1 active DMF
- COHANCE LIFESCIENCES LTD1 active DMF
- COHANCE LIFESCIENCES LTD1 active DMF
- COHANCE LIFESCIENCES LTD1 active DMF
- ANGELINI ACRAF SPA1 active DMF
- RISING PHARMA HOLDINGS INCUnited States1 active DMF
- COHANCE LIFESCIENCES LTD1 active DMF
- RAKS PHARMA PVT LTDIndia1 active DMF
- SYN-TECH CHEM AND PHARM CO LTD1 active DMF
- Zhejiang Hisun Pharmaceutical Co., Ltd.China1 active DMF
- ROCHE DIAGNOSTICS GMBH
- BOEHRINGER INGELHEIM CHEMICALS INC
- FRESENIUS KABI ONCOLOGY LTD
- PHARMACEUTICAL FINE CHEMICALS PFC BAHAMAS LTD
- Johnson Matthey PlcUnited Kingdom
- Lupin LimitedIndia
- FDC LimitedIndia
- CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD
- Arevipharma GmbHGermany
Patent & exclusivity (US)
Per the FDA Orange Book (8 approved US products), the latest listed US patent on Metaxalone expires 13 May 2043. Generic API sourcing typically opens up once these lapse.
Therapeutic areas
Musculoskeletal DisordersMuscle Spasms
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.